Generated Narrative
Id : equilidem-with-ing-and-auth
Identifier : Equilidem25
Combined Pharmaceutical Dose Form : tablet
Indication : Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class >= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
Legal Status Of Supply : Prescription only medicine
classification : B01A
Ingredients :
Role : active
substance : Equilidonium Phosphate
- Presentation * 22 ml/1 tablet
Role : excipient
substance : Calcium Carbonate
- Presentation * 3 ml/tablet
| - | ProductName |
| * | Equilidem 2.5 mg film-coated tablets |
| - | Product |
| * | Link to generic equivalent |
| - | Manufacturer |
| * | EquiliDrugCo Processing Inc. |